Evolution of IncA/C blaCMY-2-carrying plasmids by acquisition of the blaNDM-1 carbapenemase gene

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 783-786

  Carattoli, Alessandra ^a   Villa, Laura ^a   Poirel, Laurent ^b   Bonnin, Rémy A ^b   Nordmann, Patrice ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLACMY-2 GENE; BLANDM-1 GENE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE LOCATION; GENE SEQUENCE; INDIA; KENYA; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTOBACTERIUM DAMSELAE; PLASMID; PRIORITY JOURNAL; YERSINIA RUCKERI;

BETA-LACTAMASES; COMPUTATIONAL BIOLOGY; EVOLUTION, MOLECULAR; GRAM-NEGATIVE BACTERIA; HUMANS; KENYA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; PLASMIDS; SEQUENCE ANALYSIS, DNA;

EID: 84856074698     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05116-11     Document Type: Article

References (35)

1. Baudry PJ, Mataseje L, Zhanel GG, Hoban DJ, Mulvey MR. 2009. Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care units. Diagn. Microbiol. Infect. Dis. 65:379-383.
2. Blanc V, et al. 2008. Characterisation of plasmids encoding extended-spectrum beta-lactamase and CMY-2 in Escherichia coli isolated from animal farms. Int. J. Antimicrob. Agents 31:76-78. (Pubitemid 350236721)
3. Cain AK, Hall R. 2011. Transposon Tn5393e carrying the aphA1-containing transposon Tn6023 upstream of strAB does not confer resistance to streptomycin. Microb. Drug Resist. 17:389-394.
4. CMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob. Agents Chemother. 54:590-596.
5. Carattoli A, et al. 2006. Replicon typing of plasmids encoding resistance to newer β-lactams. Emerg. Infect. Dis. 12:1145-1148. (Pubitemid 44061290)
6. Carattoli A, et al. 2002. Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob. Agents Chemother. 46:1269-1272. (Pubitemid 34415301)
7. Chen Y, Zhou Z, Jiang Y, Yu Y. 2011. Emergence of NDM-1-producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 66:1255-1259.
8. Colinon C, Miriagou V, Carattoli A, Luzzaro F, Rossolini GM. 2007. Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 β-lactamases. J. Antimicrob. Chemother. 60:258-262. (Pubitemid 47243871)
9. CMY-2 plasmids carried by Salmonella enterica and Escherichia coli isolates from cattle in the Pacific Northwest. Appl. Environ. Microbiol. 73:8005-8011.
10. Dunne EF, et al. 2000. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase. JAMA 284:3151-3156. (Pubitemid 32039078)
11. Folster JP, et al. 2010. Characterization of extended-spectrum cephalospor-inresistant Salmonella enterica serovar Heidelberg isolated from humans in the United States. Foodborne Pathog. Dis. 7:181-187.
12. Hopkins KL, et al. 2006. Replicon typing of plasmids carrying CTX-M or CMY β-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob. Agents Chemother. 50:3203-3206. (Pubitemid 44396441)
13. Johnson TJ, et al. 2007. Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl. Environ. Microbiol. 73:1976-1983. (Pubitemid 46449082)
14. Kaase M, et al. 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66:1260-1262.
15. NDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65:2253-2254.
16. Kumarasamy KK, et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602.
17. Lindsey RL, Fedorka-Cray PJ, Frye JG, Meinersmann RJ. 2009. Inc A/C plasmids are prevalent in multidrug-resistant Salmonella enterica isolates. Appl. Environ. Microbiol. 75:1908-1915.
18. Mataseje LF, et al. 2010. Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada. Diagn. Microbiol. Infect. Dis. 67:387-391.
19. Nordmann P, Poirel L, Toleman MA, Walsh TR. 2011. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J. Antimicrob. Chemother. 66:689-692.
20. O'Mahoni R, et al. 2006. Antimicrobial resistance in nontyphoidal Salmonella from food sources in Colombia: evidence for an unusual plasmid-localized class 1 integron in serotypes Typhimurium and Anatum. Microb. Drug Resist. 12:269-277.
21. Poirel L, Bonnin RA, Nordmann P. 2011. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob. Agents Chemother. 55:4224-4229.
22. CTX-Mβ-lactamase gene. Antimicrob. Agents Chemother. 47:2938-2945.
23. NDM-1-positive Enterobacteriaceae. Antimicrob. Agents Chemother. doi:10.1128/AAC.00585-11.
24. Poirel L, Revathi G, Bernabeu S, Nordmann P. 2011. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob. Agents Chemother. 55:934-936.
25. Poirel L, et al. 2011. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J. Antimicrob. Chemother. 66:1730-1733.
26. Poirel L, et al. 2007. Expanded-spectrum β-lactamase and plasmid-mediated quinolone resistance. Emerg. Infect. Dis. 13:803-805. (Pubitemid 46698763)
27. CMY-2 producers and non-producers. Foodborne Pathog. Dis. 6:1185-1194.
28. Rye HS, et al. 1999. GroEL-GroES cycling: ATP and non-native polypeptide direct alternation of folding-active rings. Cell 97:325-338. (Pubitemid 29214589)
29. Sidjabat H, et al. 2011. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-β-lactamase. Clin. Infect. Dis. 15:481-484.
30. Toleman MA, Walsh TR. 2010. ISCR elements are key players in IncA/C plasmid evolution. Antimicrob. Agents Chemother. 54:3534.
31. Wachino J, et al. 2006. Novel plasmid-mediated 16S rRNA methylase, RmtC, found in a Proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides. Antimicrob. Agents Chemother. 50:178-184. (Pubitemid 43042919)
32. Walsh TR, Weeks J, Livermore DM, Toleman MA. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11:355-362.
33. Welch TJ, et al. 2007. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2:e309.
34. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. 2001. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45:2716-2722. (Pubitemid 32906662)
35. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.